Search
Chairs and Members
Chair (re-appointment, 2023–2026)Josef Vormoor—Professor of Hematological Malignancies in Children, University Medical Center Utrecht (The Netherlands)
Co-chair (re-appointment, 2023–2026)Maria Ester Bernardo—Clinical Coordinator, Clinical Research Unit, San Raffaele Telethon Institute for Gene Therapy (Italy)
SWG Steering Committee members (2024–2027 term)
SWG Secretary—Francesco Saglio, AOU Città…
Accommodation
Welcome to the Hotel Accommodation page for the EHA2025 Congress. Hotel Information and Official Housing Bureau
INTERPLAN AG is the official housing bureau for the EHA2025 Congress.
EHA Ranking 2025
The information on this page is also available as a printable PDF. EHA Ranking 2025 — PDF version
Position
Company
Priority points
Corporate Level
1
Johnson & Johnson
1. 488,82
Platinum
2
Bristol Myers Squibb
1.
The Clot Thickens
Haemophilia B is a genetic bleeding disorder, affecting approximately 80,000 males worldwide1, caused by an insufficient or dyfunctional blood clotting protein called factor IX (FIX).
Read moreEHA reaffirms commitment to hematology's future with new brand identity
The European Hematology Association (EHA) is thrilled to announce the launch of our new brand identity. This includes a refreshed logo, updated color palette, and a new slogan, marking a significant milestone in our journey.
Read moreNational Societies and EHA join forces for Ukraine
The European Hematology Association (EHA) and the European National Societies for Hematology want to express again, and publicly, their profound solidarity with the Ukrainian Hematology Society, and with Ukrainian hematology patients and their families.
Read moreHematology 2.0: navigating the world of medical apps
Interview with Dr Alex Langridge, SpR, by Dr Nuno Borges, MBBS, MRes, on behalf of YoungEHA. Despite the controversy surrounding them, medical apps remain extremely popular and lucrative endeavors.
Read more